Home › Free Stock Grades › MRVI
Maravai LifeSciences Holdings, Inc. (MRVI) Stock Grade
MRVI · Healthcare
C-
Market Cap
$897.6M
P/E Ratio
—
Revenue Growth (YoY)
-28.3%
Net Margin
-70.4%
Return on Equity
—
Dividend Yield
None
About Maravai LifeSciences Holdings, Inc.'s fundamentals
Maravai LifeSciences is a biotechnology company with a market capitalization of $897.6 million that has experienced significant operational challenges. The company reported a 28.3% year-over-year decline in revenue and posted a net loss with a negative net margin of 70.4% in its latest annual statement. With no dividend yield and profitability metrics unavailable, the company is currently unprofitable and not returning capital to shareholders.